Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?
- PMID: 34850381
- DOI: 10.1111/bjh.17955
Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?
Comment on
-
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.Br J Haematol. 2022 Feb;196(4):884-891. doi: 10.1111/bjh.17918. Epub 2021 Oct 28. Br J Haematol. 2022. PMID: 34713441 Free PMC article.
References
-
- Samson LW, Tarazi W, Orav EJ, Sheingold S, De Lew N, Sommers BD. Associations Between County-level Vaccination Rates and COVID-19 Outcomes Among Medicare Beneficiaries. Available from: https://aspe.hhs.gov/reports/covid-19-vaccination-rates-outcomes
-
- Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-16.
-
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-15.
-
- Sadoff J, Gray G, Vandebosch AN, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384(23):2187-201.
-
- Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, et al. COVID-19 in transplant recipients: the Spanish experience. Am J Transplant. 2021;21(5):1825-37.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical